PUT BREAST CANCER TO THE TEST

The information presented on this site is intended to provide patients with newly diagnosed invasive or pre-invasive breast cancer (medically known as Ductal Carcinoma In Situ), as well as their friends and family, an opportunity to hear how others have incorporated the information provided by the Oncotype DX® tests in making treatment decisions with their doctors. The personal stories featured on this site selected by Genomic Health, Inc., which offers the Oncotype DX tests, are not intended to be representative of patients with breast cancer generally, and should not be considered medical advice. Patients should consult their doctor to determine the best treatment decision for their individual disease.

American Society of Clinical Oncology (ASCO) and ASCO are registered trademarks of ASCO; National Comprehensive Cancer Network (NCCN) and NCCN are registered trademarks of NCCN. ASCO and NCCN do not endorse any product or therapy.

Copyright © 2004-2020 Genomic Health, Inc., an Exact Sciences corporation. All rights reserved. Genomic Health, Oncotype, Oncotype DX, Recurrence Score, DCIS Score and Pass It On: Until Every Woman Knows are registered trademarks, and Put Breast Cancer to the test and Put Chemo to the test are pending registered trademarks, of Genomic Health, Inc., an Exact Sciences corporation. MyBreastCancerTreatment.org is sponsored by Genomic Health, Inc., a clinical laboratory that developed and offers the Oncotype DX test. Genomic Health is responsible for the content of MyBreastCancerTreatment.org.